Benzinga | Mar 4, 2021 04:09PM EST

Anika Therapeutics Q4 Adj. EPS $0.12 Beats $(0.01) Estimate, Sales $32.70M Miss $33.50M Estimate

Anika Therapeutics (NASDAQ:ANIK) reported quarterly earnings of $0.12 per share which beat the analyst consensus estimate of $(0.01) by 1300 percent. This is a 72.09 percent decrease over earnings of $0.43 per share from the same period last year. The company reported quarterly sales of $32.70 million which missed the analyst consensus estimate of $33.50 million by 2.39 percent. This is a 9.83 percent increase over sales of $29.77 million the same period last year.